Company profile for PROMETHEUS LABS

PharmaCompass

Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth

Update your Virtual Booth on PharmaCompass, ask us

About

Prometheus is commited to improve lives through the development and commercialization of novel pharmaceutical and diagnostic products that enable physicians to provide greater individualized patient care. our strategy includes the marketing and deivery of propietary diagnostic testing services , scientific nutritional solutions and pharmaceutical products. By integrating these, Orometheus belives it can provide physicians with...
Prometheus is commited to improve lives through the development and commercialization of novel pharmaceutical and diagnostic products that enable physicians to provide greater individualized patient care. our strategy includes the marketing and deivery of propietary diagnostic testing services , scientific nutritional solutions and pharmaceutical products. By integrating these, Orometheus belives it can provide physicians with more trageted solution to optimize care for their patients. Prometheus became a part of Nestle Health Science in july 2011.

List your booth number for exhibitions, ask us

CONTACT DETAILS

Click the arrow to open the dropdown
Country
Country
U.S.A
Address
Address
9410 Carroll Park Drive 
Telephone
Telephone
(888) 423-5227
Linkedin
Linkedin
youtube
YouTube
Twitter
Twitter

Upload your Marketing & Sales content on your company Virtual Booth, click HERE.

Events

Webinars & Exhibitions

Tides Asia

Tides Asia

Not Confirmed

envelop Contact Supplier

Tides Asia

Post an Enquiry

Meeting

Digital content

Create Content with PharmaCompass, ask us

NEWS #PharmaBuzz

read-more
read-more

https://www.accesswire.com/860165/prometheus-laboratories-announces-new-health-plan-agreements-to-provide-precision-guided-testing-services

ACCESSWIRE
09 May 2024

https://www.accesswire.com/viewarticle.aspx?id=770281&lang=en

ACCESSWIRE
27 Jul 2023
Prometheus upsizes IPO, fueling chase of Pfizer in bowel disease
Prometheus upsizes IPO, fueling chase of Pfizer in bowel disease

12 Mar 2021

// Nick Paul Taylor FIERCEBIOTECH

https://www.fiercebiotech.com/biotech/prometheus-upsizes-ipo-fueling-chase-pfizer-bowel-disease#:~:text=Prometheus%20upsizes%20IPO%2C%20fueling%20chase%20of%20Pfizer%20in%20bowel%20disease,-by%20Nick%20Paul&text=Prometheus%20Biosciences%20has%20upsized%20its,inflammatory%20bowel%20disease%20(IBD).

Nick Paul Taylor FIERCEBIOTECH
12 Mar 2021

https://endpts.com/prometheus-upsizes-ipo-by-33-ahead-of-pricing-humanigen-secures-loan-of-up-to-80m-to-develop-lenzilumab/

Max Gelman ENDPTS
11 Mar 2021
Bausch loses Salix president to precision GI company
Bausch loses Salix president to precision GI company

06 Sep 2019

// Beth Snyder Bulik FIERCE PHARMA

https://www.fiercepharma.com/marketing/salix-pharmaceutical-president-leaves-bausch-health-for-precision-medicine-gi-company

Beth Snyder Bulik FIERCE PHARMA
06 Sep 2019

http://www.prnewswire.com/news-releases/prometheus-diagnostic-test-validated-in-anticipation-of-us-healthcare-provider-demand-for-celltrions-inflectra-biosimilar-infliximab-300248068.html

PR NEWSWIRE
07 Apr 2016

ABOUT THIS PAGE

Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty